Expres2ion Biotech Hldg Stock Fundamentals
| 5JD Stock | EUR 1.83 0.06 3.39% |
EXPRES2ION BIOTECH HLDG fundamentals help investors to digest information that contributes to EXPRES2ION BIOTECH's financial success or failures. It also enables traders to predict the movement of EXPRES2ION Stock. The fundamental analysis module provides a way to measure EXPRES2ION BIOTECH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EXPRES2ION BIOTECH stock.
EXPRES2ION |
EXPRES2ION BIOTECH HLDG Company Gross Profit Analysis
EXPRES2ION BIOTECH's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current EXPRES2ION BIOTECH Gross Profit | 6.22 M |
Most of EXPRES2ION BIOTECH's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EXPRES2ION BIOTECH HLDG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, EXPRES2ION BIOTECH HLDG reported 6.22 M of gross profit. This is 99.72% lower than that of the Healthcare sector and 99.35% lower than that of the Biotechnology industry. The gross profit for all Germany stocks is 99.98% higher than that of the company.
EXPRES2ION BIOTECH HLDG Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining EXPRES2ION BIOTECH's current stock value. Our valuation model uses many indicators to compare EXPRES2ION BIOTECH value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EXPRES2ION BIOTECH competition to find correlations between indicators driving EXPRES2ION BIOTECH's intrinsic value. More Info.EXPRES2ION BIOTECH HLDG is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the EXPRES2ION BIOTECH's earnings, one of the primary drivers of an investment's value.EXPRES2ION Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EXPRES2ION BIOTECH's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EXPRES2ION BIOTECH could also be used in its relative valuation, which is a method of valuing EXPRES2ION BIOTECH by comparing valuation metrics of similar companies.EXPRES2ION BIOTECH is currently under evaluation in gross profit category among its peers.
EXPRES2ION Fundamentals
| Return On Equity | -0.57 | |||
| Return On Asset | -0.34 | |||
| Shares Outstanding | 37.15 M | |||
| Shares Owned By Institutions | 1.71 % | |||
| Gross Profit | 6.22 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 12.79 X | |||
| Number Of Employees | 27 | |||
| Beta | 1.46 | |||
| Market Capitalization | 44 M |
About EXPRES2ION BIOTECH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EXPRES2ION BIOTECH HLDG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EXPRES2ION BIOTECH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EXPRES2ION BIOTECH HLDG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.ExpreS2ion Biotech Holding AB , through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops a platform technology that enables the production of complex proteins for new vaccines and diagnostics of malaria. ExpreS2ion Biotech Holding AB is based in Horsholm, Denmark. EXPRES2ION BIOTECH operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 17 people.
Currently Active Assets on Macroaxis
Other Information on Investing in EXPRES2ION Stock
EXPRES2ION BIOTECH financial ratios help investors to determine whether EXPRES2ION Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EXPRES2ION with respect to the benefits of owning EXPRES2ION BIOTECH security.